Structure Therapeutics Inc. (GPCR) stock

GPCRNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30

$20.00+0.16 (+0.81%)

Close on Nov 13, 2026Market cap $1.43BP/E –Yield –

Structure Therapeutics statistics

62 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Feb 25, 2027 (estimated, during market hours)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $1.43B; $272.32M
Enterprise Value: $186.20M; $146.23M
PB Ratio: 1.17; 2.00
P/TBV Ratio: 1.17; 2.22

Share statisticsIndustry

Shares Outstanding: 214M; 58M
Shares Change (YoY): 22.0%; 10.8%
Shares Change (QoQ): 0.20%; 0.50%
Float: 208M; 49M
Shares Held by Insiders: 2.73%; 11.7%
Shares Held by Institutions: 31.6%; 56.4%

Short sellingIndustry

Short Interest: 6M; –
Short Interest Change: -17.1%; -0.80%
Days to Cover: 6.50; 5.15

Stock price statisticsIndustry

52-Week High: $94.90; –
52-Week Low: $18.70; –
20-Day Moving Average: $21.13; –
50-Day Moving Average: $27.89; –
200-Day Moving Average: $45.60; –
Average True Range (14): $1.52; –
Price Change (1 Week): -1.72%; -1.15%
Price Change (1 Month): -9.87%; -4.87%
Price Change (3 Months): -62.8%; -21.0%
Price Change (6 Months): -48.3%; -20.6%
Price Change (YTD): -71.2%; -23.6%
Price Change (1 Year): -44.3%; -22.4%
Price Change (3 Years): -62.7%; -29.5%
Average Volume (10 Days): 1M; –
Average Volume (20 Days): 995,078; –
Average Volume (90 Days): 1M; –
Relative Volume: 1.36; 0.70
Relative Strength Index (14): 33.1; 43.4
Volatility (1 Year): 119.0%; 80.1%
Beta (5 Years): 1.18; 1.07

Returns on capitalIndustry

Return on Equity (ROE): -29.5%; -49.9%
Return on Assets (ROA): -27.1%; -40.6%
Return on Capital Employed (ROCE): -27.7%; -37.9%

Financial positionIndustry

Current Ratio: 11.91; 3.30
Quick Ratio: 11.58; 2.39

EfficiencyIndustry

Profits Per Employee: -$1.34M; -$689.41K
Employee Count: 220; 74
WACC: 11.0%; 10.2%

Income statement (TTM)Industry

Operating Income: -$340.35M; -$21.37M
Pretax Income: -$293.12M; -$12.95M
Net Income: -$293.88M; -$22.35M
EBITDA: -$340.35M; -$17.21M
EPS (Diluted): -$1.33; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $1.24B; $68.68M
Net Cash (Debt): $1.24B; $17.76M
Net Cash Per Share: $5.80; $0.80
Equity (Book Value): $1.22B; $53.89M
Book Value Per Share: $5.71; $1.50
Tangible Book Value: $1.22B; $27.13M
Working Capital: $1.17B; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$271.00M; -$12.38M
Capital Expenditures: -$6.28M; -$1.00M
Free Cash Flow: -$277.28M; -$18.21M
FCF Per Share: -$1.30; -$0.42

Dividends and yieldsIndustry

Earnings Yield: -20.6%; -21.8%
FCF Yield: -19.4%; -9.44%

Taxes and interestIndustry

Income Tax: $765.00K; $73.00K

Scores and fair valueIndustry

Altman Z-Score: 6.98; 0.23
Piotroski F-Score: 3; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	GPCR	S&P 500	Difference	GPCR per year	S&P 500 per year
1 month	-10.4%	-3.0%	−7.3 pts
3 months	-63.4%	-2.8%	−60.7 pts
Year to date	-71.2%	+11.5%	−82.7 pts
1 year	-42.9%	+13.5%	−56.3 pts
3 years	-63.4%	+77.7%	−141.1 pts	-28.5%	+21.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

6M GPCR shares were sold short on Oct 30, 2026, down 17.1% from the previous report. At recent volumes it would take 6.5 days to buy them back. Over the last 20 sessions, 35.8% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	5,927,622	-17.1%	911,823	6.5
Oct 15, 2026	7,147,328	-5.2%	1,497,742	4.8
Sep 30, 2026	7,540,480	+14.2%	1,458,682	5.2
Sep 15, 2026	6,605,011	+12.8%	1,262,278	5.2
Aug 31, 2026	5,854,907	-3.7%	740,185	7.9
Aug 14, 2026	6,079,970	+0.5%	585,763	10.4
Jul 31, 2026	6,049,938	-2.5%	528,506	11.4
Jul 15, 2026	6,206,238	+1.3%	703,317	8.8
Jun 30, 2026	6,127,886	+4.0%	978,055	6.3
Jun 15, 2026	5,893,905	+5.8%	826,251	7.1
May 29, 2026	5,572,394	-1.4%	618,035	9.0
May 15, 2026	5,651,873	-5.4%	770,632	7.3

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?